We are Sorry, This Page doesn't Exist
Arbutus Biopharma Corp (ABUS) Q4 2018 Earnings Conference Call Transcript
ABUS earnings call for the period ending December 31, 2018......»»
Arbutus Biopharma Corp. (ABUS) CEO Mark Murray on Q4 2018 Results - Earnings Call Transcript
Arbutus Biopharma Corp. (ABUS) CEO Mark Murray on Q4 2018 Results - Earnings Call Transcript.....»»
Analyst Downgrades Arbutus Biopharma On Valuation After 80% Run
Arbutus Biopharma Corp (NASDAQ: ABUS) stock has gained 80 percent since the turn of the year, and B. Riley FBR dropped its bullish stance Friday in the wake of the rally.  Latest Ra.....»»
Arbutus Biopharma Corp (ABUS) CEO Mark Murray on Q2 2018 Results - Earnings Call Transcript
Arbutus Biopharma Corp (ABUS) CEO Mark Murray on Q2 2018 Results - Earnings Call Transcript.....»»
Christina Lake Cannabis Provides Bi-Weekly Update on Status of MCTO
VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. ("CLC" or the "Company") (CSE:CLC) is providing an update with respect to the expected timeline for filing its audited financial statements fo.....»»
Strongbridge Biopharma announces FDA filing acceptance of NDA for recorlev
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Arbutus Biopharma reports Q1 EPS (21c), consensus (23)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Arbutus Biopharma price target lowered to $7 from $8 at B. Riley Securities
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Arbutus Biopharma sees cash runway into 3Q22
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Arbutus Biopharma reports 2020 EPS ($1.00), consensus (98c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Cannae Holdings announces Austerlitz Acquisition Corp. II filing of S-1
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Arbutus Biopharma sees cash runway into mid-2022
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Arbutus Biopharma announces 2021 corporate objectives
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Arbutus Biopharma initiated with a Buy at H.C. Wainwright
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Arbutus Biopharma initiates program to find medicines to treat COVID-19
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Arbutus Biopharma reports Q1 EPS (25c), consensus (39c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ceres Global Ag Corp. to Host its Q3 2020 Results Conference Call on May 29, 2020, and Announces Filing Extension of Interim Financial Results pursuant to CF Blanket Order
MINNEAPOLIS, MN, May 8, 2020 /CNW/ - Ceres Global Ag Corp. (TSX:CRP) ("Ceres" or the "Company") announced that it will be reporting its fisc.....»»
Arbutus Biopharma says COVID-19 may impact timelines on AB-729 trials
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Hexo delays filing of financial statements as it looks to book "significant" impairment loss
Hexo Corp. said Tuesday it missed the March 16 deadline to file its interim financial statements for the 3-month and 6-month .....»»